Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Raloxifene Hydrochloride MeSH Descriptor Data 2025


MeSH Heading
Raloxifene Hydrochloride
Tree Number(s)
D02.455.426.559.389.150.700.900.775
Unique ID
D020849
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D020849
Scope Note
A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.
Entry Term(s)
Evista
Keoxifene
Keoxifene Hydrochloride
LY 139481
LY 156758
LY-139481
LY-156758
Raloxifene
Raloxifene HCl
Pharm Action
Estrogen Antagonists
Selective Estrogen Receptor Modulators
Bone Density Conservation Agents
Registry Numbers
4F86W47BR6
0
YX9162EO3I
Related Numbers
82640-04-8
84449-90-1
YX9162EO3I
Previous Indexing
Piperidines (1983-1999)
Public MeSH Note
2000; LY 139481 (now RALOXIFENE) was indexed under PIPERIDINES 1983-1999
History Note
2000; use RALOXIFENE (NM) 1983-1999
Date Established
2000/01/01
Date of Entry
1999/11/03
Revision Date
2015/07/08
Raloxifene Hydrochloride Preferred
LY-156758 Narrower
Raloxifene Broader
LY-139481 Narrower
Evista Narrower
page delivered in 0.146s